Fulgent Genetics Inc (NAS:FLGT)
$ 21.74 -0.37 (-1.67%) Market Cap: 650.55 Mil Enterprise Value: 368.33 Mil PE Ratio: 0 PB Ratio: 0.58 GF Score: 74/100

Q2 2019 Fulgent Genetics Inc Earnings Call Transcript

Aug 05, 2019 / 08:30PM GMT
Release Date Price: $8.05 (+3.47%)
Operator

Good afternoon, ladies and gentlemen, and welcome to the Q3 2019 Fulgent Genetics Earnings Conference Call. (Operator Instructions) As a reminder, this conference call is being recorded.

I would now like to turn the conference over to your host, Ms. Nicole Borsje from Investor Relations. Ma'am, please go ahead.

Nicole Borsje
The Blueshirt Group, LLC - MD of IR

Great. Thank you. Good afternoon and welcome to the Fulgent Genetics Second Quarter 2019 Financial Results Conference Call. On the call today is Ming Hsieh, Chief Executive Officer; and Paul Kim, Chief Financial Officer.

The company's press release discussing its financial results is available on the Investor Relations section of the company's website, fulgentgenetics.com. An audio replay of this call will be available shortly after the call concludes. Please visit the Investor Relations section of the company's website to access the audio replay.

Management's prepared remarks and answers to your questions on today's call will contain forward-looking statements. These forward

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot